Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Atopy and altered T cell functions contribute to Alopecia Areata.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.

Oral baricitinib is effective and safe for treating alopecia areata.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Both treatments for alopecia areata are equally effective and safe.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.